These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9932229)

  • 1. Mutation of C-terminal tyrosine residues Y497/Y504 of the Src-family member Bsk/Iyk decreases NIH3T3 cell proliferation.
    Oberg-Welsh C; Annerén C; Welsh M
    Growth Factors; 1998; 16(2):111-24. PubMed ID: 9932229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Bsk/Iyk non-receptor tyrosine kinase for the control of growth and hormone production in RINm5F cells.
    Annerén C; Welsh M
    Growth Factors; 2000; 17(4):233-47. PubMed ID: 10801074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone-dependent nuclear localization of the tyrosine kinase iyk in the normal human breast epithelium and loss of expression during carcinogenesis.
    Berclaz G; Altermatt HJ; Rohrbach V; Dreher E; Ziemiecki A; Andres AC
    Int J Cancer; 2000 Mar; 85(6):889-94. PubMed ID: 10709113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cytokine-induced cytotoxicity of pancreatic islet cells from transgenic mice expressing the Src-like tyrosine kinase GTK.
    Annerén C; Welsh M
    Mol Med; 2001 May; 7(5):301-10. PubMed ID: 11474576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity.
    Welsh M; Welsh C; Ekman M; Dixelius J; Hägerkvist R; Annerén C; Akerblom B; Mahboobi S; Chandrasekharan S; Liu ET
    Biochem J; 2004 Aug; 382(Pt 1):261-8. PubMed ID: 15186217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation.
    Annerén C; Lindholm CK; Kriz V; Welsh M
    Curr Mol Med; 2003 Jun; 3(4):313-24. PubMed ID: 12776987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tyrosine kinase signaling for beta-cell replication and survival.
    Welsh M; Annerén C; Lindholm C; Kriz V; Oberg-Welsh C
    Ups J Med Sci; 2000; 105(2):7-15. PubMed ID: 11095102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases.
    Serfas MS; Tyner AL
    Oncol Res; 2003; 13(6-10):409-19. PubMed ID: 12725532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between c-src tyrosine kinase activity and the control of glucose transporter gene expression.
    Matsouka PT; Flier JS
    Mol Endocrinol; 1989 Nov; 3(11):1845-51. PubMed ID: 2481817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.
    Nakaigawa N; Weirich G; Schmidt L; Zbar B
    Oncogene; 2000 Jun; 19(26):2996-3002. PubMed ID: 10871851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of BSK, a murine FRK homologue with a specific pattern of tissue distribution.
    Oberg-Welsh C; Welsh M
    Gene; 1995 Jan; 152(2):239-42. PubMed ID: 7835707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of a Ca2+-dependent K+ current in mouse fibroblasts by sphingosine-1-phosphate involves the protein tyrosine kinase c-Src.
    Repp H; Birringer J; Koschinski A; Dreyer F
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):295-301. PubMed ID: 11284444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis.
    Zamorano J; Keegan AD
    J Immunol; 1998 Jul; 161(2):859-67. PubMed ID: 9670964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
    Huang WC; Chen JJ; Inoue H; Chen CC
    J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
    Annerén C; Welsh M
    Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor.
    Calleja V; Ruiz Enríquez P; Filloux C; Peraldi P; Baron V; Van Obberghen E
    Endocrinology; 1997 Mar; 138(3):1111-20. PubMed ID: 9048617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation.
    Sekimoto H; Boney CM
    Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.